Dr. Rishabh Kumar

Senior Consultant

12 Years of Experience

Radiation Oncologist

MBBS, MD, Fellowship

Amrita Hospital, Faridabad

English, Hindi, Kannada, Tamil

Consultation Fee ₹ 1200

Book an Appointment Contact with Doctor

Confirm Your Consultation With Dr. Rishabh Kumar

Expert Help When You Need It – Plan in 60 Minutes

Name*

Mobile Number*

Is the above number on WhatsApp? *

Yes

Query

About Dr. Rishabh Kumar

Dr. Rishabh Kumar is a distinguished Radiation Oncologist with over 12 years of experience.
He specializes in utilizing advanced radiation technologies for Brain, Head, and Neck, Breast, Gastrointestinal, and Gynecological cancers, etc.
He is proficient in various brachytherapy techniques for Breast, Sarcomas, Cervix, Prostate, Lung, and Liver cancers, as well as IGRT SRS and SBRT treatments.
His educational qualifications include an MBBS from Pondicherry Institute of Medical Sciences/Pondicherry University in 2012 and an MD (Radiation Oncology) from Vydehi Institute of Medical Sciences/Rajiv Gandhi University of Health Sciences), in 2017.
Dr. Kumar received specialized training to administer personalized, high-precision radiation therapy with minimal side effects.
He commissioned Stereotactic programs in ablative radiotherapy at ILBS Delhi, leading to significant publications in Liver SBRT for Hepatocellular carcinomas.
He was instrumental in implementing MRI-guided Brachytherapy for cervical cancer and conducted pioneering research in liver brachytherapy and HPV/telomerase roles in cancers.
He received the MC Pant Gold Medal for outstanding research in Radiation Oncology in 2016
Dr. Kumar was awarded a technology transfer grant by the European Society of Therapeutic Radiology and Oncology for advanced training in Cyberknife-based SRS and SBRT, proton therapy, and Hyperthermia at ERASMUS.
He was recognized with the Best Young Radiation Oncologist award and GC Pant Gold Medal at AROICON Ahmedabad 2019 for research contributions.
He contributed to the Low Dose Radiation for COVID-19 trial at AIIMS New Delhi.
Dr. Kumar is involved in developing breast brachytherapy guidelines by the Indian Brachytherapy Society.
He is fluent in English, Hindi, Tamil, and Kannada.

Confirm Your Consultation With Dr. Rishabh Kumar

Expert Help When You Need It – Plan in 60 Minutes

Name*

Mobile Number*

Is the above number on WhatsApp? *

Yes

Query

Education

MBBS, Pondicherry Institute of Medical Sciences/Pondicherry University, 2012
MD, (Radiation Oncology), Vydehi Institute of Medical Sciences/Rajiv Gandhi University of Health Sciences), 2017
ESTRO Fellow, ERASMUS MC, Rotterdam, South Holland, Netherlands, 2017

OPD Schedule Of Dr. Rishabh Kumar

Book Appointment

Past Experience

Senior Resident, All India Institute of Medical Sciences, 2022
Senior Resident, Institute of Liver And Biliary Sciences, 2020
Senior Resident, Sanjay Gandhi Postgraduate Institute of Medical Sciences, 2018
Senior Resident, Delhi State Cancer Institute (DSCI), 2018
Junior Resident, Vydehi Institute Of Medical Sciences and Research Centre, 2017
Intern Sir Ganga Ram Hospital, 2012

MC Pant Gold Medal, 2016
GC Pant Gold Medal, 2019
Best Young Radiation Oncologist Award, 2019

Revolutionizing cancer treatment in India: Evaluating the unmet need, economics, and a roadmap for project implementation of particle therapy
Is hepatocellular carcinoma complicated with portal vein tumor thrombosis potentially curable by radiotherapy in the form of stereotactic body radiation therapy?
Can low-dose radiation therapy reduce the risk of mucormycosis in COVID-19 patients?
Identifying Patterns of Failure and Risk Factors for Recurrence in Patients of Paratesticular Sarcomas: Protocol of a Systematic Review and Meta-Analysis
Efficacy and toxicity of SBRT in advanced hepatocellular carcinoma with portal vein tumor thrombosis -a retrospective study
Dosimetric impact of contrast-enhanced 4D computed tomography for stereotactic body radiation therapy of hepatocellular carcinoma
Low-dose radiotherapy for COVID-19: A radioimmunological perspective
Impact of dose heterogeneity in target on TCP and NTCP for various radiobiological models in liver SBRT: Different isodose prescription strategy
Technical illustration of Volumetric arc conformal radiotherapy planning in a case of para-testicular sarcoma
Low Dose Radiation Therapy for COVID-19 Pneumonia: Why do we need another treatment modality that may be futile vs. challenging opposition
Surface mold brachytherapy planning in giant cell tumor of the tendon sheath of finger and a dosimetric comparison with external beam radiotherapy: a case report
Efficacy and Toxicity of SBRT in Advanced Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis: A Retrospective Study
A prospective comparative dosimetric study between diffusion-weighted MRI (DWI) & T2-weighted MRI (T2W) for target delineation and planning in cervical cancer brachytherapy
Effectiveness of Progressive Muscle Relaxation Therapy on Physical Symptoms among Cancer Patients receiving Chemotherapy admitted to Cancer Unit of the Institute of Liver and Biliary Sciences, Delhi
Evaluation and evolution of apparent diffusion coefficient (ADC) in image-guided adaptive brachytherapy (IGABT) for cervical cancer
Dosimetric comparison of dynamic conformal arc integrated with segment shape optimization and variable dose rate versus volumetric modulated arc therapy for liver SBRT
Feasibility of 4D CT simulation with synchronized intravenous contrast injection in hepatocellular carcinoma
Change of telomerase activity in peripheral blood of patients with head and neck squamous cell carcinoma pre and post-curative treatment
Comparison of treatment response in cervical carcinoma patients infected with human papillomavirus 16 and human papillomavirus 18 who are treated with chemoradiation
The promise of image-guided brachytherapy of better clinical outcomes in the treatment of cervical cancer: Does it deliver? An Indian scenario
Evaluation of Apparent diffusion coefficient(ADC) in Image-guided brachytherapy for cervical cancer
A rare case of cisplatin-induced acute myocardial infarction in a patient receiving chemoradiation for lung cancer